- Home
- AKRO vs TFPM Comparison
AKRO vs TFPM Comparison
Compare AKRO & TFPM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- AKRO
- TFPM
- Stock Information
- Founded
- AKRO 2017
- TFPM 2016
- Country
- AKRO United States
- TFPM Canada
- Employees
- AKRO N/A
- TFPM N/A
- Industry
- AKRO Biotechnology: Pharmaceutical Preparations
- TFPM Precious Metals
- Sector
- AKRO Health Care
- TFPM Industrials
- Exchange
- AKRO Nasdaq
- TFPM Nasdaq
- Market Cap
- AKRO 3.9B
- TFPM 4.3B
- IPO Year
- AKRO 2019
- TFPM N/A
- Fundamental
- Price
- AKRO $54.58
- TFPM $23.55
- Analyst Decision
- AKRO Strong Buy
- TFPM Strong Buy
- Analyst Count
- AKRO 6
- TFPM 3
- Target Price
- AKRO $82.50
- TFPM $23.67
- AVG Volume (30 Days)
- AKRO 1.8M
- TFPM 469.1K
- Earning Date
- AKRO 08-08-2025
- TFPM 08-18-2025
- Dividend Yield
- AKRO N/A
- TFPM 0.93%
- EPS Growth
- AKRO N/A
- TFPM N/A
- EPS
- AKRO N/A
- TFPM 0.02
- Revenue
- AKRO N/A
- TFPM $293,708,000.00
- Revenue This Year
- AKRO N/A
- TFPM $19.66
- Revenue Next Year
- AKRO N/A
- TFPM $0.85
- P/E Ratio
- AKRO N/A
- TFPM $952.71
- Revenue Growth
- AKRO N/A
- TFPM 39.01
- 52 Week Low
- AKRO $21.02
- TFPM $13.94
- 52 Week High
- AKRO $58.40
- TFPM $25.45
- Technical
- Relative Strength Index (RSI)
- AKRO 68.00
- TFPM 46.82
- Support Level
- AKRO $53.05
- TFPM $24.26
- Resistance Level
- AKRO $56.49
- TFPM $25.41
- Average True Range (ATR)
- AKRO 2.44
- TFPM 0.58
- MACD
- AKRO -0.26
- TFPM -0.24
- Stochastic Oscillator
- AKRO 86.02
- TFPM 9.51
About AKRO Akero Therapeutics Inc.
Akero Therapeutics Inc is a clinical-stage biotechnology company focused on developing and commercializing transformative treatments for serious metabolic diseases with high unmet medical needs. Its focus is nonalcoholic steatohepatitis (MASH), or NASH, a disease without any approved therapies. The company's product candidate efruxifermin is an FGF21 analog with properties that have the potential to address the core processes underlying NASH pathogenesis.
About TFPM Triple Flag Precious Metals Corp.
Triple Flag Precious Metals Corp is a streaming and royalty company focused on precious metals. Its revenues are largely generated from a diversified portfolio of properties in Australia, Canada, Colombia, Cote d'Ivoire, Mexico, Mongolia, Peru, South Africa, and the United States. Its diversified portfolio of streams and royalties comprises long-life mining assets, including the Northparkes copper-gold mine in Australia, the Cerro Lindo polymetallic mine in Peru, the Fosterville gold mine in Australia, the Buritica gold mine in Colombia, and the Impala Bafokeng Operations in South Africa among others. A majority of its revenue is derived through its interests in various gold streams. Geographically, the company derives maximum revenue from Australia, followed by Peru and other regions.